West Pharmaceutical Services Inc - Cost of Goods Sold Including Depreciation and Amortization

West Pharmaceutical Services Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Cost-of-Goods-Sold-Including-Depreciation-and-Amortization" stands at 1.94 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.

West Pharmaceutical Services Inc's third quarter result of 0.5108 Billion USD for the item "Cost of Goods Sold Including Depreciation and Amortization" represents an increase of 3.61 percent compared to it's second quarter result.

Also, West Pharmaceutical Services Inc's third quarter result of 0.5108 Billion USD for the item "Cost of Goods Sold Including Depreciation and Amortization" represents an increase of 6.04 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), West Pharmaceutical Services Inc's third quarter result of 1.94 Billion USD for the item "Cost of Goods Sold Including Depreciation and Amortization" represents an increase of 1.52 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 3.95 percent compared to the value the year prior.
The 1 year change in percent is 3.95.
The 3 year change in percent is 11.56.
The 5 year change in percent is 45.94.
The 10 year change in percent is 105.87.

The Serie's long term average value is 1.28 Billion United States Dollars. It's latest available value, on 09/30/2025, is 51.25 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2011, to it's latest available value, on 09/30/2025, is +127.83%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.